Search tips
Search criteria 


Logo of molcellbPermissionsJournals.ASM.orgJournalMCB ArticleJournal InfoAuthorsReviewers
Mol Cell Biol. 2004 February; 24(3): 1168–1173.
PMCID: PMC321451

More than blood, a Novel Gene Required for Mammalian Postimplantation Development


More than blood (Mtb) is a novel gene that is widely expressed in mouse embryos prior to gastrulation but is subsequently restricted to specific tissues, including the developing central nervous system and hematopoietic organs. Since MTB is highly expressed in the fetal liver and developing thymus, we predicted that MTB would be required for hematopoiesis and that embryos deficient in MTB would die of anemia. Surprisingly, embryos with a targeted disruption of Mtb died prior to the initiation of blood cell development, immediately following implantation. This lethality is due to a defect in expansion of the inner cell mass (ICM), as Mtb−/− blastocysts failed to exhibit outgrowth of the ICM, both in vitro and in vivo. Furthermore, Mtb−/− blastocysts exhibited a higher frequency of apoptotic cells than wild-type or heterozygous blastocysts. These findings demonstrate that Mtb is a novel gene that is essential for early embryonic development.

Gene targeting studies have highlighted the importance of many genes in preimplantation and immediate postimplantation development of the mouse embryo. Early embryonic development requires proteins that are known to be involved in a wide array of cellular processes, including growth factor signaling, cell adhesion, cell cycle regulation, DNA replication and repair, chromatin modifications, and transcription. Fibroblast growth factor 4, which is expressed by the inner cell mass (ICM), and its receptor, fibroblast growth factor receptor 2, are both required for proper expansion of the blastocyst upon implantation (1, 6). E-cadherin and β1 integrin, two proteins involved in cell adhesion, are required for preimplantation and postimplantation development, respectively (11, 19, 25). Deletion of cell cycle regulators, such as cyclin A2 or cdc7, also results in peri-implantation embryonic lethality (9, 14). Several proteins involved in DNA replication and repair, including cdc45, a putative DNA polymerase loading factor (29), members of the ATR/ATM superfamily of cell cycle checkpoint genes (2, 4), Chk1 (12), and Rad51 (26), are necessary for pregastrulation development of the mouse embryo. Chromatin maintenance and modifying activities, such as components of the SWI/SNF complex (7, 10) and polycomb-related proteins (16), also play a critical role in early embryogenesis. Finally, various proteins involved in transcription, from basal transcription factors such as TFIIH (3, 21) to ubiquitous transcription factors such as YY1 (5) to lineage-restricted regulators such as Oct-4 (15), are also essential for early embryonic development in the mouse. A major challenge in analyzing these early developmental defects is distinguishing those genes that are essential for basic cellular viability from those that are specifically required for a developmental program.

One of the best-studied regulators of early mammalian development is the POU domain transcription factor Oct-4 mentioned above. In the early embryo, Oct-4 functions at the first differentiation event in determining whether a cell is destined to become part of the trophectoderm or the ICM, which generate the extraembryonic tissues, including the placenta, or the embryo proper, respectively (for a review, see reference 17). In the absence of Oct-4, all blastomeres become trophoblasts, and the embryo dies shortly after implantation (15). The requirement for Oct-4 in the specification of embryo-derived stem cells is unique, because Oct-4 is not ubiquitously expressed, nor does it play a role in general cellular function.

While Oct-4 is not known to regulate somatic stem cells, transcription factors of the basic helix-loop-helix (bHLH) family are involved in lineage specification in multiple tissues, including blood, brain, and muscle. Class I bHLH proteins, which include the products of the E2A gene (E12 and E47), HEB, and E2-2, form homo- and/or heterodimers that bind DNA of the consensus site CANNTG (for a review, see reference 13). Although these proteins are ubiquitously expressed, gene targeting studies with mice have uncovered specific roles for these factors in B- and T-cell development (18). The absence of more widespread deficiencies in these single-gene-targeted mice indicates that the family members exhibit redundant roles in nonlymphoid lineages (30). In contrast, the class II bHLH factors are expressed in a tissue-specific manner. These factors typically interact with DNA as heterodimers with E-proteins and activate transcription of lineage-specific genes. Essential class II proteins include the muscle factors myogenin and myoD, the neural factor MASH-1, and the hematopoietic protein SCL/tal-1. SCL is required for embryonic specification of hematopoietic stem cells, as mice lacking SCL die in utero between embryonic day 8.5 (E8.5) and E10.5 due to a complete absence of blood cells (20, 24).

In this study, we describe the cloning and targeted deletion of a novel gene named More than blood (Mtb). Mtb is widely expressed in mouse embryos prior to gastrulation but then is expressed primarily at sites of neurogenesis and hematopoiesis in embryos at mid- to late gestation and in adult mice. Although MTB was identified in a yeast two-hybrid screen for SCL-interacting proteins, the physiological relevance of this putative association has not been established. It is clear, however, that MTB is required for early embryonic development and is essential for viability and expansion of the ICM of the implanting blastocyst. Mtb joins an expanding list of genes whose activity is required at early stages of mammalian development.


Yeast two-hybrid screen.

Full-length SCL cDNA was fused in frame to the DNA binding domain of Gal4 in the pGBT9 vector (Clontech). The library contained cDNAs from MEL cells fused in frame to the Gal4 activation domain (AD) in plasmid pGADGL (Clontech). MaV103 yeast cells (27) were cotransformed with the bait and prey by standard methods. Clones harboring interacting proteins were selected on SD medium lacking Leu, Trp, and His and with 10 mM 3-amino-1,2,4-triazole. Positive clones were restreaked to SD medium lacking Leu, Trp, and Ura to determine whether the interaction could drive a second reporter, Ura3. Cells were also analyzed for LacZ expression by standard filter assays. DNAs from 10 positive clones were isolated by standard methods and then transfected into bacteria by electroporation. The library plasmids were identified and sequenced to reveal the interacting gene. Of the 10 clones that activated both reporters, 6 harbored DNAs encoding the class A bHLH protein ALF-1 (mouse homologue of HEB), 1 encoded murine transcription factor A1 (a leucine zipper-bHLH protein), and the final 3 clones contained identical fragments of MTB.

Cloning of full-length Mtb.

The MTB fragment obtained from the yeast two-hybrid screen (named AD4) was approximately 650 bp in length and was predicted to encode 211 amino acids. We probed a murine cDNA phage library with this MTB fragment, according to standard methods (23), and identified two overlapping phage clones. In addition, we performed both 5′ and 3′ rapid amplification of cDNA ends (RACE), using the SMART RACE cDNA amplification kit (Clontech). The complete Mtb coding sequence is 2.5 kb and is predicted to encode a polypeptide of 849 amino acids.

Northern blots and in situ expression analysis.

Total RNA or poly(A)+ RNA was isolated from various murine cell lines or tissues by using Trizol reagent (Invitrogen). The remaining Northern blots were purchased from Clontech. Northern blots were hybridized with various portions of radiolabeled MTB cDNA. For in situ hybridization, an antisense RNA probe corresponding to the MTB AD4 fragment or an antisense SCL RNA was prepared by using digoxigenin-UTP (Boehringer Mannheim), and in situ hybridization was performed as described previously (28).

Gene targeting and genotyping.

The targeting vector was constructed in pBluescript KS(−) with herpes simplex virus thymidine kinase inserted into the SalI site and LoxP-neomycin inserted into the NotI site, with flanking by a 10-kb SacI-XbaI genomic fragment for the 5′ homology region and a 4-kb BamHI-SpeI genomic fragment for the 3′ homology region. Upon homologous recombination, the neomycin cassette replaces bp 937 to 2293 of the 2.5-kb coding region. The targeting construct was electroporated into CJ7/129 embryonic stem cells and selected with 280 μg of neomycin per ml. Genomic DNA was isolated from neomycin-resistant clones, digested with SacI, and genotyped by Southern blotting with a 200-bp probe (bp 2298 to 2498 of the coding region). One Mtb+/− clone with a normal diploid number was identified from approximately 500 clones screened and was used for subsequent injection into C57BL/6 blastocysts. The injected blastocysts were then implanted into pseudopregnant females to generate chimeric mice. Mtb chimeric males were crossed with wild-type C57BL/6 females to generate germ line Mtb+/− progeny. The first 10 litters were genotyped by Southern blot analysis as described above, and the subsequent litters and embryos were genotyped by single-reaction PCR with the primers Wt1For (5′ TTCATCACCACCATCCAG 3′), Neo1For (5′ CTCCAGACTGCCTTGGGAAAAG 3′), and Com3Rev (5′ CAGAGCAGTCCTGAATAGTCTG 3′) to generate products of 434 bp for the wild-type allele and 616 bp for the targeted allele. PCR genotyping reactions were performed in mixtures containing 1× buffer 6 (Stratagene), 200 μM deoxynucleoside triphosphates, a 1 μM concentration of each forward primer, a 2 μM concentration of the common reverse primer, 10% dimethyl sulfoxide, and 1 μl of Klentaq DNA polymerase (Clontech) with the following program: 94°C for 3 min; 30 cycles of 94°C for 45 s, 60°C for 1 min, and 72°C for 1 min; and a final 10-min extension at 72°C.

Embryo isolation and culture.

To determine the stage of embryonic lethality, timed matings were established between Mtb+/− males and females. Noon of the day a vaginal plug was detected was defined as 0.5 day postcoitum. Embryos from E3.5 to E12.5 were isolated essentially as previously described (8). For blastocyst cultures, blastocysts were flushed from dissected uterine horns in M2 medium (Sigma), and zona pellucidae were removed by pronase treatment (8). Blastocysts were cultured on gelatinized embryo dishes (Becton Dickinson) in embryonic stem cell medium (high-glucose Dulbecco's modified Eagle's medium [Invitrogen])-15% fetal calf serum (HyClone)-penicillin-streptomycin-200 mM l-glutamine-1% nucleoside mix plus leukemia inhibitory factor (LIF) (1,000 U/ml) for 3 to 6 days. Following the growth period, cultured blastocysts were harvested by trypsinization, resuspended in 10 μl of embryo lysis buffer (1% Triton X-100, 50 mM Tris [pH 8], 20 mM NaCl, 1 mM EDTA) with 100 ng of proteinase K per μl, and digested overnight at 55°C. Following heat inactivation of proteinase K, 5 μl of embryo lysate was genotyped by nested PCR. In the first round, primers Wt1For, Neo2For (5′ CAAAGCTGCTATTGGCCGCTG 3′), and Com3Rev were used for 30 cycles of 94°C for 45 s, 55°C for 45 s, and 72°C for 90 s. This amplification reaction generates a wild-type product of 434 bp and a mutant product of 905 bp. One microliter of this 50-μl PCR product was used as the template for the second round of PCR with primers Wt1For, Neo1For, and Com2Rev (5′ GGAGTGATGGCATCC TCAGCAC 3′), with a program of 30 cycles of 94°C for 45 s, 60°C for 60 s, and 72°C for 60 s. The final products are 285 bp (wild-type allele) and 466 bp (mutant allele).

TUNEL assays.

Terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL) assays were performed on freshly isolated blastocysts from Mtb heterozygous matings at E3.5. The blastocysts were fixed in freshly prepared 4% paraformaldehyde in phosphate-buffered saline (PBS) and washed in PBS with 5% bovine serum albumin, and TUNEL reactions were performed with an in situ cell death detection kit (fluorescein label) (Roche). Blastocysts were stained with 1 μg of Hoechst 33342 (Intergen) per ml to detect nuclei. TUNEL positivity was detected by fluorescence microscopy with a Zeiss Axiovert 100TV microscope, a Micromax digital camera, and Slidebook 3.0 and Openlab 3.1 imaging software (University of Chicago Cancer Research Center Digital Light Microscopy Facility). TUNEL-positive nuclei were quantitated by performing a digital Z stack through the blastocyst. Following imaging, blastocysts were washed in PBS with 5% bovine serum albumin, transferred to 10 μl of embryo lysis buffer, and processed for genotyping by nested PCR as described above.

Nucleotide sequence accession number.

The MTB cDNA sequence has been deposited in GenBank under accession number AY455829.


Cloning of Mtb.

MTB was isolated in a yeast two-hybrid screen for SCL-interacting proteins. The Mtb fragment obtained from the yeast two-hybrid screen comprised the extreme C-terminal domain of the protein (residues 639 to 849, named the AD4 fragment). To clone the entire cDNA, we screened a phage library with the AD4 fragment and additionally performed both 5′ and 3′ RACE. The complete Mtb cDNA is 6.8 kb and is predicted to encode a protein of 849 amino acids with little similarity to known proteins. MTB contains weak homology to a leucine zipper motif and harbors several putative casein kinase II and protein kinase C phosphorylation sites (Fig. (Fig.11 and data not shown). Database searches revealed that Mtb is a novel murine gene with a human homologue, a predicted gene named FLJ20311. Murine Mtb and human FLJ20311 are highly homologous at both the DNA (87% identity) and protein (80% identity) levels.

FIG. 1.
Amino acid sequence of murine MTB. The region with homology to a leucine zipper domain is shaded.

MTB is initially widely expressed in embryos but then becomes enriched in sites of hematopoiesis and neurogenesis in the developing embryo and adult mice.

We performed both in situ hybridization of mouse embryos and Northern blot analyses to determine the expression profile of MTB. Two transcripts of MTB were detected in a Northern blot of RNA from embryos as early as E7.0, the stage when yolk sac hematopoiesis is initiated (Fig. (Fig.2A).2A). These two transcripts differ in the 5′ and 3′ untranslated regions. Whole-mount in situ hybridization demonstrated that MTB is widely expressed in embryos at both E6.5 and E8.5 (Fig. (Fig.3A3A and data not shown). However, MTB expression is subsequently restricted to specific regions of the embryo, including the developing fetal liver, the site of definitive hematopoiesis, at both E12.5 and E15.5 (Fig. 3B and C). In addition, MTB expression is detected in the thymus at E15.5, as well as in the midbrain, forebrain, and the olfactory epithelium (Fig. 3C, D, and E). In adult mice, MTB is expressed in the spleen, lung, and testis, as well as in all hematopoietic cell lines tested, including megakaryocytes and erythroid, myeloid, and lymphoid cells (Fig. 2B and C and data not shown). Expression was not detected in NIH 3T3 cells or adult muscle tissue (data not shown). Together, these expression data illustrate that MTB exhibits a broad expression profile in early embryos and that MTB is later enriched in hematopoietic and neuronal lineages.

FIG. 2.
Northern blot analysis of MTB expression during embryogenesis, in adult tissues, and in hematopoietic cell lines. (A) MTB expression can be detected as early as E7.0, as revealed by hybridization of a Clontech embryonic tissue blot with the C-terminal ...
FIG. 3.
MTB expression in early- and mid-gestation embryos. (A) Whole-mount in situ hybridization, using the AD4 probe, of a wild-type embryo at E8.5 highlights the broad expression pattern of MTB at this early stage of development. (B) In situ hybridization ...

Disruption of the Mtb locus results in embryonic lethality.

In order to examine the role of MTB in vivo, we disrupted the Mtb locus in embryonic stem cells (Fig. (Fig.4A)4A) and subsequently injected Mtb+/− embryonic stem cells into wild-type blastocysts to generate chimeric mice. Chimeric males were mated to wild-type females to generate germ line Mtb+/− mice. Southern and PCR genotyping strategies were used to identify mutant mice (Fig. 4B and C). Mtb heterozygous mice were normal at birth, grew at a rate similar to that of their wild-type littermates, and were fertile. The Mtb+/− males and females were bred to generate Mtb−/− progeny. After genotyping over 30 litters from heterozygous matings, no Mtb−/− pups were identified, indicating that disruption of the Mtb locus resulted in embryonic lethality (Table (Table1).1). Genotyping of embryos from E6.5 to E12.5 demonstrated that Mtb−/− embryos died prior to blood cell development and even before gastrulation (Table (Table1).1). Furthermore, approximately 25% of the embryos analyzed between E6.5 and E12.5 were resorbed (Table (Table1).1). This high frequency of resorption suggested that Mtb-deficient embryos implant normally but then fail to develop. To confirm this, we analyzed embryos in stained uterine sections at E5.5 (Fig. 5A and B). While the majority of embryos at this stage have generated an egg cylinder (Fig. (Fig.5A),5A), approximately 25% of the embryos were developmentally delayed (Fig. (Fig.5B).5B). These findings support the conclusion that Mtb-deficient embryos implant but fail to undergo the proliferative burst that normally leads to the formation of the egg cylinder. This analysis demonstrates that MTB is required for postimplantation development.

FIG. 4.
Targeted disruption of Mtb. (A) Targeting strategy for the Mtb locus, replacing approximately 1.3 kb of coding sequence in the middle of the locus with the neomycin cassette. Open boxes indicate known coding exons, and shaded boxes indicate the probe ...
FIG. 5.
Mtb−/− embryos fail to undergo a proliferative burst in vivo and in vitro. (A and B) Hematoxylin- and eosin-stained sections of mouse uterus containing presumed wild-type (A) and Mtb−/− (B) embryos at E5.5. (C and D) Blastocyst ...
Disruption of Mtb results in embryonic lethality prior to gastrulation

Mtb is required for ICM and embryonic stem cell growth.

To further characterize the growth defect of Mtb−/− embryos, we isolated blastocysts from the uteri of pregnant Mtb+/− females at E3.5, prior to implantation. Wild-type and Mtb−/− blastocysts were indistinguishable upon isolation. Blastocysts were then cultured on gelatinized tissue culture dishes in embryonic stem cell medium containing LIF for 3 to 6 days and subsequently genotyped by PCR. All blastocysts attached, and trophoblasts adhered to the culture dish normally. The ICMs of both wild-type and Mtb+/− embryos formed a large outgrowth after several days in culture, whereas the Mtb−/− blastocysts failed to generate an ICM outgrowth (Fig. 5C and D). Together, these data demonstrate that MTB is necessary for the proliferative burst of the ICM both in vivo (Fig. 5A and B) and in vitro (Fig. 5C and D). Furthermore, these results indicate that MTB is essential for growth of ICM stem cells, the embryonic population from which pluripotent embryonic stem cells are derived. An intrinsic requirement for MTB in embryo-derived stem cells is also supported by our inability to generate Mtb−/− embryonic stem cell lines by multiple methods, including neomycin step-up protocols, retargeting of the wild-type allele, and blastocyst culturing (data not shown). Consistent with this requirement for MTB in early embryonic development, MTB transcripts were detected in embryonic stem cells by reverse transcription-PCR (data not shown).

Mtb is required for survival and proliferation of the ICM.

We suspected that the Mtb−/− ICM was undergoing cell death by some mechanism, because we observed a high frequency of cells with pyknotic nuclei in sections of these embryos at E5.5 (Fig. (Fig.55 and data not shown). Therefore, Mtb−/− blastocysts were fixed at E3.5, subjected to TUNEL analysis to detect cells undergoing apoptosis, and subsequently genotyped by PCR. Mtb−/− blastocysts did contain a significantly higher number of TUNEL positive nuclei than their wild-type or Mtb+/− littermates (Fig. (Fig.66).

FIG. 6.
Increased incidence of apoptosis in Mtb−/− blastocysts. Blastocysts were isolated at E3.5, fixed, and subjected to TUNEL. (A) Quantitation of TUNEL positivity was performed by fluorescence microscopy (see Materials and Methods). Mtb−/− ...

If MTB is critical for mediating a cell survival signal in embryonic stem cells, then the absence of p53, a major regulator of cell survival that induces apoptosis, might allow Mtb−/− embryos to survive beyond implantation. The absence of p53 can prolong survival of embryos lacking tumor susceptibility gene tsg101, a putative transcriptional corepressor, for 2 days (22). To determine whether loss of p53 could partially rescue the phenotype in mice with a targeted disruption in Mtb, we crossed the Mtb mutation into a p53 null background and interbred Mtb+/−, p53−/− progeny. Embryos from these crosses were dissected and genotyped by PCR at E6.5. No Mtb−/− embryos were identified from 31 embryos, indicating that the loss of p53 did not rescue the growth defect in Mtb−/− embryos. These data demonstrate that Mtb null embryos do not die as a result of a p53-dependent survival defect and support the conclusion that MTB is required for maintenance of the ICM-derived stem cell population in postimplantation development.


Disruption of the Mtb locus results in peri-implantation lethality due to a failure of Mtb−/− embryos to undergo the proliferative burst that generates an egg cylinder upon implantation. Our in vitro analysis of blastocysts isolated from Mtb heterozygous crosses demonstrates that the Mtb−/− ICM has a severe growth defect. This growth defect was not rescued by the loss of p53, indicating that Mtb−/− cells exhibit a p53-independent survival defect and/or a proliferation defect. The requirement for MTB in pluripotent cells is further supported by our inability to generate Mtb−/− embryonic stem cell lines. Thus, we have identified a novel gene that plays a key role in early embryonic development in the mouse. The human homologue of MTB, hypothetical protein FLJ20311, is moderately expressed in human embryonic stem cells as well (24a), suggesting that MTB is likely to have a conserved function in mammalian embryo-derived stem cells. Given the expression pattern and phenotype, it is possible that MTB specifically functions in rapidly proliferating tissues, such as the pluripotent cells in early embryos and sites of neurogenesis and hematopoiesis later in embryogenesis and in the adult. The early embryonic lethality of Mtb−/− embryos precludes analysis of MTB in neuronal and hematopoietic tissues. Future studies will address the specific functions of MTB, on a molecular level, in these different cell populations, with particular emphasis on the role of MTB in early embryogenesis.


We thank Steven Droho and Josh Wechsler for excellent technical assistance; Barbara Kee, Harinder Singh, and Brian Kennedy for helpful insights and discussions; and Sandeep Gurbuxani and Steven Kosak for critical reading of the manuscript.

This research was funded, in part, by NIH grant DK61464-01 (to J.D.C) and by a grant from the V Foundation for Cancer Research (to J.D.C.). J.D.C. is a recipient of a Burroughs Wellcome Fund Career Award in the Biomedical Sciences. S.H.O. is an investigator of the Howard Hughes Medical Institute.


1. Arman, E., R. Haffner-Krausz, Y. Chen, J. K. Heath, and P. Lonai. 1998. Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. Proc. Natl. Acad. Sci. USA 95:5082-5087. [PubMed]
2. Brown, E. J., and D. Baltimore. 2000. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev. 14:397-402. [PubMed]
3. de Boer, J., I. Donker, J. de Wit, J. H. Hoeijmakers, and G. Weeda. 1998. Disruption of the mouse xeroderma pigmentosum group D DNA repair/basal transcription gene results in preimplantation lethality. Cancer Res. 58:89-94. [PubMed]
4. de Klein, A., M. Muijtjens, R. van Os, Y. Verhoeven, B. Smit, A. M. Carr, A. R. Lehmann, and J. H. Hoeijmakers. 2000. Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice. Curr. Biol. 10:479-482. [PubMed]
5. Donohoe, M. E., X. Zhang, L. McGinnis, J. Biggers, E. Li, and Y. Shi. 1999. Targeted disruption of mouse Yin Yang 1 transcription factor results in peri-implantation lethality. Mol. Cell. Biol. 19:7237-7244. [PMC free article] [PubMed]
6. Feldman, B., W. Poueymirou, V. E. Papaioannou, T. M. DeChiara, and M. Goldfarb. 1995. Requirement of FGF-4 for postimplantation mouse development. Science 267:246-249. [PubMed]
7. Guidi, C. J., A. T. Sands, B. P. Zambrowicz, T. K. Turner, D. A. Demers, W. Webster, T. W. Smith, A. N. Imbalzano, and S. N. Jones. 2001. Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice. Mol. Cell. Biol. 21:3598-3603. [PMC free article] [PubMed]
8. Hogan, B. B., F. Constantini, and E. Lacy. 1994. Manipulating the mouse embryo: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
9. Kim, J. M., K. Nakao, K. Nakamura, I. Saito, M. Katsuki, K. Arai, and H. Masai. 2002. Inactivation of Cdc7 kinase in mouse ES cells results in S-phase arrest and p53-dependent cell death. EMBO J. 21:2168-2179. [PubMed]
10. Klochendler-Yeivin, A., L. Fiette, J. Barra, C. Muchardt, C. Babinet, and M. Yaniv. 2000. The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression. EMBO Rep. 1:500-506. [PubMed]
11. Larue, L., M. Ohsugi, J. Hirchenhain, and R. Kemler. 1994. E-cadherin null mutant embryos fail to form a trophectoderm epithelium. Proc. Natl. Acad. Sci. USA 91:8263-8267. [PubMed]
12. Liu, Q., S. Guntuku, X. S. Cui, S. Matsuoka, D. Cortez, K. Tamai, G. Luo, S. Carattini-Rivera, F. DeMayo, A. Bradley, L. A. Donehower, and S. J. Elledge. 2000. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev. 14:1448-1459. [PubMed]
13. Massari, M. E., and C. Murre. 2000. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol. Cell. Biol. 20:429-440. [PMC free article] [PubMed]
14. Murphy, M., M. G. Stinnakre, C. Senamaud-Beaufort, N. J. Winston, C. Sweeney, M. Kubelka, M. Carrington, C. Brechot, and J. Sobczak-Thepot. 1997. Delayed early embryonic lethality following disruption of the murine cyclin A2 gene. Nat. Genet. 15:83-86. [PubMed]
15. Nichols, J., B. Zevnik, K. Anastassiadis, H. Niwa, D. Klewe-Nebenius, I. Chambers, H. Scholer, and A. Smith. 1998. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95:379-391. [PubMed]
16. O'Carroll, D., S. Erhardt, M. Pagani, S. C. Barton, M. A. Surani, and T. Jenuwein. 2001. The polycomb-group gene Ezh2 is required for early mouse development. Mol. Cell. Biol. 21:4330-4336. [PMC free article] [PubMed]
17. Pesce, M., and H. R. Scholer. 2001. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 19:271-278. [PubMed]
18. Quong, M. W., W. J. Romanow, and C. Murre. 2002. E protein function in lymphocyte development. Annu. Rev. Immunol. 20:301-322. [PubMed]
19. Riethmacher, D., V. Brinkmann, and C. Birchmeier. 1995. A targeted mutation in the mouse E-cadherin gene results in defective preimplantation development. Proc. Natl. Acad. Sci. USA 92:855-859. [PubMed]
20. Robb, L., I. Lyons, R. Li, L. Hartley, F. Kontgen, R. P. Harvey, D. Metcalf, and C. G. Begley. 1995. Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc. Natl. Acad. Sci. USA 92:7075-7079. [PubMed]
21. Rossi, D. J., A. Londesborough, N. Korsisaari, A. Pihlak, E. Lehtonen, M. Henkemeyer, and T. P. Makela. 2001. Inability to enter S phase and defective RNA polymerase II CTD phosphorylation in mice lacking Mat1. EMBO J. 20:2844-2856. [PubMed]
22. Ruland, J., C. Sirard, A. Elia, D. MacPherson, A. Wakeham, L. Li, J. L. de la Pompa, S. N. Cohen, and T. W. Mak. 2001. p53 accumulation, defective cell proliferation, and early embryonic lethality in mice lacking tsg101. Proc. Natl. Acad. Sci. USA 98:1859-1864. [PubMed]
23. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
24. Shivdasani, R. A., and S. H. Orkin. 1995. Erythropoiesis and globin gene expression in mice lacking the transcription factor NF-E2. Proc. Natl. Acad. Sci. USA 92:8690-8694. [PubMed]
24a. Sperger, J. M., X. Chen, J. S. Draper, J. E. Antosiewicz, C. H. Chan, S. B. Jones, J. D. Brooks, P. W. Andrews, P. O. Brown, and J. A. Thomson. 2003. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc. Natl. Acad. Sci. USA 100:13350-13355. [PubMed]
25. Stephens, L. E., A. E. Sutherland, I. V. Klimanskaya, A. Andrieux, J. Meneses, R. A. Pedersen, and C. H. Damsky. 1995. Deletion of beta 1 integrins in mice results in inner cell mass failure and peri-implantation lethality. Genes Dev. 9:1883-1895. [PubMed]
26. Tsuzuki, T., Y. Fujii, K. Sakumi, Y. Tominaga, K. Nakao, M. Sekiguchi, A. Matsushiro, Y. Yoshimura, and T. Morita. 1996. Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc. Natl. Acad. Sci. USA 93:6236-6240. [PubMed]
27. Vidal, M., R. K. Brachmann, A. Fattaey, E. Harlow, and J. D. Boeke. 1996. Reverse two-hybrid and one-hybrid systems to detect dissociation of protein-protein and DNA-protein interactions. Proc. Natl. Acad. Sci. USA 93:10315-10320. [PubMed]
28. Wilkenson, D. 1992. In situ hybridization. IRL, New York, N.Y.
29. Yoshida, K., F. Kuo, E. L. George, A. H. Sharpe, and A. Dutta. 2001. Requirement of CDC45 for postimplantation mouse development. Mol. Cell. Biol. 21:4598-4603. [PMC free article] [PubMed]
30. Zhuang, Y., C. G. Kim, S. Bartelmez, P. Cheng, M. Groudine, and H. Weintraub. 1992. Helix-loop-helix transcription factors E12 and E47 are not essential for skeletal or cardiac myogenesis, erythropoiesis, chondrogenesis, or neurogenesis. Proc. Natl. Acad. Sci. USA 89:12132-12136. [PubMed]

Articles from Molecular and Cellular Biology are provided here courtesy of American Society for Microbiology (ASM)